AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.003135
+0.000135 (4.50%)
At close: Jul 29, 2026
AXIM Biotechnologies Market Cap
AXIM Biotechnologies has a market cap or net worth of $1.09 million as of July 29, 2026. Its market cap has decreased by -52.87% in one year.
Market Cap
1.09M
Enterprise Value
n/a
Revenue
92.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since October 9, 2013, AXIM Biotechnologies's market cap has decreased from 1.98M to 1.09M, a decrease of -44.98%. That is a compound annual growth rate of -4.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 1.09M | -71.37% |
| Dec 31, 2025 | 3.81M | 528.02% |
| Dec 31, 2024 | 605.90K | -86.58% |
| Dec 29, 2023 | 4.52M | -12.57% |
| Dec 30, 2022 | 5.16M | -91.35% |
| Dec 31, 2021 | 59.71M | 10.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sirona Biochem | 1.35M |
| inTerra Resources | 1.30M |
| Neon Bloom | 1.27M |
| Abpro Holdings | 1.21M |
| Avenue Therapeutics | 1.17M |
| Nymox Pharmaceutical | 1.06M |
| Evofem Biosciences | 1.00M |
| ZyVersa Therapeutics | 939.13K |